Schulz Fran bought SNTI
March 7, 2025 · Form 4 insider transaction
Schulz Fran bought 43,900 shares of Senti Biosciences Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
43,900
Price
$0.00
Total value
N/A
InsiderSchulz Fran
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 7, 2025
Filing dateMarch 11, 2025
Shares owned after43,900
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date.